Evidence map›Paper›PMID 27186304›Full record

ArticleAmerican journal of translational research2016

Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi.

Xiwen Liao, Chuangye Han, Wei Qin, Xiaoguang Liu, Long Yu, Sicong Lu, Zhiwei Chen, Guangzhi Zhu, Hao Su, Zengnan Mo and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xiwen LiaoDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Chuangye HanDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Wei QinDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Xiaoguang LiuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Long YuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Sicong LuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Zhiwei ChenDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Guangzhi ZhuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Hao SuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Zengnan MoCenter for Genomic and Personalized Medicine, Guangxi Medical University Nanning, 530021, Guangxi Province, China.
Xue QinDepartment of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University Nanning 530021, Guangxi Province, China.
Tao PengDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University Nanning, 530021, Guangxi Province, China.
First Affiliated Hospital of GuangXi Medical University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe genome-wide association approach was employed to explore the association between single nucleotide polymorphisms (SNPs) and TP53 expression in the HBV-related hepatocellular carcinoma (HCC) of Chinese patients in Guangxi.

methods403 HBV-related HCC patients were recruited into this study and classified according to the TP53 expression in the cancer by immunohistochemistry. DNA was extracted from the cancer and genotyped with the Human ExomeBeadChip 12v1-1 system; quality control and principal-component analysis (PCA) were applied for data analysis.

resultsThe Genome-wide association analysis indicated that rs2797992 with a P value of 4.35 × 10(-5) locus in PLCE1 gene and rs6950826 with a P value of 2.2 × 10(-3) locus in EGFR gene were associated with TP53 expression in the HCC. A allele of rs2797992 predicted a decreased risk for TP53 expression in HCC. In contrast, A allele of rs6950826 increased the risk for TP53 expression. There was no strong LD locus in the tested regions. PLCE1 and EGFR were associated with TP53 in pathway and at HCC mRNA level.

conclusionrs2797992 of PLCE1 gene and rs6950826 of EGFR gene are associated with TP53 expression, but not with the prognosis of HBV-related HCC in HBV-related HCC of Chinese patients in Guangxi.

Indexed as

EGFRhepatitis B virushepatocellular carcinomaPLCE1TP53

Identifiers

PMID27186304
PMCPMC4859909
OpenAlexW2409212372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.